This medication is a phosphate binder, prescribed to reduce serum phosphate in patients with end stage renal disease. It blocks the absorption of phosphate in the body.
PO- Initial dose is 750 mg to 1.5 g/day in divided doses.
It comes as a chewable tablet to take by mouth with food.
• It may cause dizziness, drowsiness. Do not drive a car or operate machinery while taking this medication.
• Caution needed while using in patients with history of ulcer, ulcerative colitis, Crohn's disease, bowel obstruction and during pregnancy.
• Gastrointestinal :
Stomach upset, vomiting, stomach pain, diarrhea and constipation.
• Miscellaneous : Problems with the dialysis graft, headache, dizziness and blurred vision.
Avoid excess dosage.
Store it at controlled room temperature (59° to 86°F). Protect from moisture.
Subscribe to our Free Newsletters!
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...View All